TCAPITAL TRANSACTIONS

T-Capital Transactions - Transaction Cases

Healthcare capital transaction cases and project practices.

01 SELECTED TRANSACTIONS

Selected Transaction Cases.

Explore T-Capital's involvement in healthcare capital transaction projects over time.

Ractigen Therapeutics Completes 110 Million RMB Series A Financing, with T-Capital as Financial Advisor
2021 Private Financing Innovative Drugs

Ractigen Therapeutics Completes 110 Million RMB Series A Financing, with T-Capital as Financial Advisor

In February 2021, Ractigen Therapeutics completed a 110 million RMB Series A financing. This round was led by GL Ventures, with co-investments from CCB Medical Growth Fund, Bohai Capital, and Longmen Capital, and T-Capital acted as the financial advisor. Ractigen Therapeutics focuses on RNA activation (RNAa) technology and the R&D of small activating RNA drugs, developing innovative nucleic acid drugs for the global market.

View Transaction →
Transduction Bio Completes Angel+ Round Financing, with T-Capital as Financial Advisor
2021 Private Financing Biotechnology

Transduction Bio Completes Angel+ Round Financing, with T-Capital as Financial Advisor

Transduction Bio has completed its Angel+ round of financing, co-led by CCB Medical Growth Fund and YuanSheng Ventures, with participation from Hongtai Fund and Huagai Capital. The proceeds will be mainly used to accelerate the development of its RNA drug pipeline and the construction of its LNP production platform. T-Capital acted as the financial advisor.

View Transaction →
Yizhun Intelligence Completes Nearly 100 Million RMB Series B Financing, with T-Capital as Financial Advisor
2020 Private Financing Medical AI

Yizhun Intelligence Completes Nearly 100 Million RMB Series B Financing, with T-Capital as Financial Advisor

On March 19, 2020, medical imaging AI company Beijing Yizhun Intelligence Technology Co., Ltd. completed a nearly 100 million RMB Series B financing, with T-Capital acting as the financial advisor. The round was led by the Wondfo Biotech industry fund managed by Sanmei Investment, with co-investors including Xiaomiao Langcheng, Hanergy Venture Capital, and Qingsong Fund.

View Transaction →
TCAPITAL TRANSACTIONS

Considering a
healthcare transaction?

If you are considering financing, M&A, divestiture, licensing & business development, or a strategic partnership, we invite you to discuss your. project with the T-Capital team.

Contact Us →